Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Pedro Faria Zeni & Marek Mraz. (2021) LncRNAs in adaptive immunity: role in physiological and pathological conditions. RNA Biology 18:5, pages 619-632.
Read now
Read now
Fortunato Morabito, Massimo Gentile, Paola Monti, Anna Grazia Recchia, Paola Menichini, Mamdouh Skafi, Moien Atrash, Giuseppa De Luca, Sabrina Bossio, Hamdi Al-Janazreh, Sara Galimberti, Zaidoun Salah, Lucio Morabito, Alham Mujahed, Musa Hindiyeh, Mariella Dono, Franco Fais, Giovanna Cutrona, Antonino Neri, Giovanni Tripepi, Gilberto Fronza & Manlio Ferrarini. (2020) TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors. Expert Opinion on Investigational Drugs 29:8, pages 869-880.
Read now
Read now
Articles from other publishers (20)
Cynthia M. Magro, Taylor Kalomeris & Alice Roberts. (2023) Primary cutaneous blastic marginal zone lymphoma: A comprehensive clinical, light microscopic, phenotypic and cytogenetic appraisal. Annals of Diagnostic Pathology 63, pages 152101.
Crossref
Crossref
Andriana Valkama, Sandra Vorimo, Timo A. Kumpula, Hannele Räsänen, Eeva-Riitta Savolainen, Katri Pylkäs & Tuomo Mantere. (2023) Optical Genome Mapping as an Alternative to FISH-Based Cytogenetic Assessment in Chronic Lymphocytic Leukemia. Cancers 15:4, pages 1294.
Crossref
Crossref
Sylwia Chocholska, Michał Zarobkiewicz, Agata Szymańska, Natalia Lehman, Justyna Woś & Agnieszka Bojarska-Junak. (2023) Prognostic Value of the miR-17~92 Cluster in Chronic Lymphocytic Leukemia. International Journal of Molecular Sciences 24:2, pages 1705.
Crossref
Crossref
Giulio Donati & Bruno Amati. (2022)
MYC
and therapy resistance in cancer: risks and opportunities
. Molecular Oncology 16:21, pages 3828-3854.
Crossref
Crossref
Colin J. Daniel, Carl Pelz, Xiaoyan Wang, Michael W. Munks, Aaron Ko, Dhaarini Murugan, Sarah A. Byers, Eleonora Juarez, Karyn L. Taylor, Guang Fan, Lisa M. Coussens, Jason M. Link & Rosalie C. Sears. (2022) T-cell Dysfunction upon Expression of MYC with Altered Phosphorylation at Threonine 58 and Serine 62. Molecular Cancer Research 20:7, pages 1151-1165.
Crossref
Crossref
Eva Ondroušková, Michaela Bohúnová, Kristýna Závacká, Patrik Čech, Petra Šmuhařová, Miroslav Boudný, Martina Oršulová, Anna Panovská, Lenka Radová, Michael Doubek, Karla Plevová & Marie Jarošová. (2022) Duplication of 8q24 in Chronic Lymphocytic Leukemia: Cytogenetic and Molecular Biologic Analysis of MYC Aberrations. Frontiers in Oncology 12.
Crossref
Crossref
Fansheng Ran, Yun Liu, Chen Wang, Zhongyuan Xu, Yanan Zhang, Yang Liu, Guisen Zhao & Yong Ling. (2022) Review of the development of BTK inhibitors in overcoming the clinical limitations of ibrutinib. European Journal of Medicinal Chemistry 229, pages 114009.
Crossref
Crossref
Florence Nguyen-Khac. (2022) “Double-Hit” Chronic Lymphocytic Leukemia, Involving the TP53 and MYC Genes. Frontiers in Oncology 11.
Crossref
Crossref
David E. Spaner. (2021) O-GlcNAcylation in Chronic Lymphocytic Leukemia and Other Blood Cancers. Frontiers in Immunology 12.
Crossref
Crossref
Seyed Esmaeil Ahmadi, Samira Rahimi, Bahman Zarandi, Rouzbeh Chegeni & Majid Safa. (2021) MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies. Journal of Hematology & Oncology 14:1.
Crossref
Crossref
Lucile Bussot, Simon Chevalier, Justine Cristante, Béatrice Grange, Bruno Tesson, Clémence Deteix‐Santana, Frédérique Orsini‐Piocelle, Cécile Leyronnas, Sophie Dupire, Rémy Gressin, Gilles Salles, Emmanuel Bachy, Anouk Emadali, Séverine Valmary‐Degano, Sarah Huet, Christine Lefebvre & Sylvain Carras. (2021)
Adverse outcome in follicular lymphoma is associated with
MYC
rearrangements but not
MYC
extra copies
. British Journal of Haematology 194:2, pages 382-392.
Crossref
Crossref
Masahiro Horita, Colin Farquharson & Louise A Stephen. (2021) The role of miR‐29 family in disease. Journal of Cellular Biochemistry 122:7, pages 696-715.
Crossref
Crossref
Ryutaro Takada, Tomohiro Watanabe, Ikue Sekai, Keisuke Yoshikawa, Akane Hara, Yasuo Otsuka, Tomoe Yoshikawa, Ken Kamata, Kosuke Minaga, Yoriaki Komeda, Takaaki Chikugo, Yasuyuki Arai, Kohei Yamashita & Masatoshi Kudo. (2021) Case Report: Concurrent Occurrence of Abdominal Double Expressor Lymphoma and Jejunum Follicular Lymphoma. Frontiers in Oncology 11.
Crossref
Crossref
Francesca Vittoria Sbrana, Riccardo Pinos, Federica Barbaglio, Davide Ribezzi, Fiorella Scagnoli, Lydia Scarfò, Itedale Namro Redwan, Hector Martinez, Silvia Farè, Paolo Ghia & Cristina Scielzo. (2021) 3D Bioprinting Allows the Establishment of Long-Term 3D Culture Model for Chronic Lymphocytic Leukemia Cells. Frontiers in Immunology 12.
Crossref
Crossref
Pinelopi I. Artemaki, Petros A. Letsos, Ioanna C. Zoupa, Katerina Katsaraki, Paraskevi Karousi, Sotirios G. Papageorgiou, Vasiliki Pappa, Andreas Scorilas & Christos K. Kontos. (2021) The Multifaceted Role and Utility of MicroRNAs in Indolent B-Cell Non-Hodgkin Lymphomas. Biomedicines 9:4, pages 333.
Crossref
Crossref
Benedetta Apollonio, Nikolaos Ioannou, Despoina Papazoglou & Alan G. Ramsay. (2021) Understanding the Immune-Stroma Microenvironment in B Cell Malignancies for Effective Immunotherapy. Frontiers in Oncology 11.
Crossref
Crossref
Oleksi Petrenko, Jinyu Li, Velasco Cimica, Patricio Mena-Taboada, Ha Youn Shin, Stephen D’Amico & Nancy C. Reich. (2021) IL-6 promotes MYC-induced B cell lymphomagenesis independent of STAT3. PLOS ONE 16:3, pages e0247394.
Crossref
Crossref
Javier Arzuaga-Mendez, Maria Lopez-Santillan, Juan Carlos Garcia-Ruiz, Elixabet Lopez-Lopez & Idoia Martin-Guerrero. (2021) Systematic review of the potential of MicroRNAs in the management of patients with follicular lymphoma. Critical Reviews in Oncology/Hematology 159, pages 103247.
Crossref
Crossref
Siba El Hussein, Kenna R.M. Shaw & Francisco Vega. (2020) Evolving insights into the genomic complexity and immune landscape of diffuse large B-cell lymphoma: opportunities for novel biomarkers. Modern Pathology 33:12, pages 2422-2436.
Crossref
Crossref
Laura Ondrisova & Marek Mraz. (2020) Genetic and Non-Genetic Mechanisms of Resistance to BCR Signaling Inhibitors in B Cell Malignancies. Frontiers in Oncology 10.
Crossref
Crossref